glyceraldehyde 3-phosphate dehydrogenase (304-313) and Cardiovascular Stroke

glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Califf, RM; Edwards, S; Gallo, P; Henis, M; Kober, L; Leimberger, JD; Maggioni, AP; McMurray, JV; Pfeffer, MA; Rouleau, JL; Sellers, MA; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, HD	1

Other Studies

1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and Cardiovascular Stroke

Article	Year
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. European journal of heart failure, 2003, Volume: 5, Issue:4 Topics: Aged; Angiotensin Receptor Antagonists; Captopril; Double-Blind Method; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptide Fragments; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left	2003

Article

Year

VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.

European journal of heart failure, 2003, Volume: 5, Issue:4

Topics: Aged; Angiotensin Receptor Antagonists; Captopril; Double-Blind Method; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptide Fragments; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left

2003